{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T23:04:15Z","timestamp":1770246255734,"version":"3.49.0"},"posted":{"date-parts":[[2025,7,8]]},"group-title":"In Review","reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,5,30]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Introduction<\/bold>\n                  Both COVID-19 disease and HIV infection\n                  <italic>in utero<\/italic>\n                  are associated with increased risk of adverse pregnancy outcomes. However, there is limited evidence on the impact of mild SARS-CoV-2 infection during pregnancy in sub-Saharan Africa, particularly among women living with HIV (WLWH), who may face heightened risk of adverse effects due to immune dysregulation and elevated obstetric risks.\n                  <bold>Methods<\/bold>\n                  We conducted a prospective cohort study of pregnant women enrolled at 20\u201336 weeks gestation at two health facilities in southern Malawi between 2018 and 2022. SARS-CoV-2 infection was determined via serologic testing at enrollment and delivery. Participants were enrolled into three groups based on HIV status and viral suppression: (1) WLWH with detectable viral load (VL), (2) WLWH with undetectable VL, and (3) HIV-negative women. We used multivariable logistic regression with adjustment for confounding to evaluate the impact of SARS-CoV-2 infection on the following adverse birth outcomes: low birth weight (LBW), preterm birth, small-for-gestational-age (SGA), stillbirth or early neonatal death, and a composite outcome. We further assessed any interaction between SARS-CoV-2 infection and HIV infection on adverse birth outcomes.\n                  <bold>Results<\/bold>\n                  Among 905 women, 29% tested positive for SARS-CoV-2 during pregnancy. Most (87%) infections were mild or asymptomatic. In the total population, SARS-CoV-2 infection was significantly associated with SGA births (adjusted OR [aOR]: 1.49, 95% CI: 1.03\u20132.13) but was not associated with other adverse outcomes. Among WLWH, SARS-CoV-2 positivity was significantly associated with increased odds of LBW (aOR: 2.07, 95% CI: 1.10\u20133.91) and SGA births (aOR: 1.73, 95% CI: 1.01\u20132.91). The effect of SARS-CoV-2 infection among WLWH did not differ based on VL.\n                  <bold>Conclusion<\/bold>\n                  Mild SARS-CoV-2 infection during pregnancy was associated with adverse birth outcomes, particularly among WLWH, suggesting HIV-related immune modulation may heighten vulnerability to adverse pregnancy outcomes in the context of other infectious exposures. These findings underscore the need for integrated antenatal care and targeted infection prevention strategies for pregnant women with HIV in high-burden settings. Additionally, in light of recent changes in recommendations for COVID-19 vaccinations, these findings highlight the ongoing need for infection prevention among pregnant women globally.\n                <\/p>","DOI":"10.21203\/rs.3.rs-6787028\/v1","type":"posted-content","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:20:12Z","timestamp":1751941212000},"source":"Crossref","is-referenced-by-count":0,"title":["Adverse Birth Outcomes Associated with SARS-CoV-2 Infection Among Pregnant Women with and without HIV: A Longitudinal Cohort Study"],"prefix":"10.21203","author":[{"given":"Ibrahim Ahmed","family":"El-Imam","sequence":"first","affiliation":[{"name":"University of Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abra Rachida","family":"Koudjra","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nginache","family":"Nampota-Nkomba","sequence":"additional","affiliation":[{"name":"University of Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Mkandawire","sequence":"additional","affiliation":[{"name":"Kamuzu University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osward","family":"Nyirenda","sequence":"additional","affiliation":[{"name":"Kamuzu University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoda","family":"Masonga","sequence":"additional","affiliation":[{"name":"Kamuzu University of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Cairo","sequence":"additional","affiliation":[{"name":"University of Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Gladstone","sequence":"additional","affiliation":[{"name":"University of Liverpool"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam K.","family":"Laufer","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea G.","family":"Buchwald","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","author":"Wolff D","year":"2021","unstructured":"Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Vol. 49, Infection. Springer Science and Business Media Deutschland GmbH; 2021. pp. 15\u201328."},{"issue":"12","key":"ref2","article-title":"The Risk of SARS-CoV-2 Infection in Pregnant Women: An Observational Cohort Study Using the BIFAP Database","volume":"10","author":"Mota M","year":"2022","unstructured":"Mota M, Huerta-\u00c1lvarez C, Llorente A, Cea-Soriano L. The Risk of SARS-CoV-2 Infection in Pregnant Women: An Observational Cohort Study Using the BIFAP Database. Healthc (Switzerland). 2022;10(12).","journal-title":"Healthc (Switzerland)"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255999","article-title":"COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes","volume":"16","author":"Shoaib N","year":"2021","unstructured":"Shoaib N, Noureen N, Munir R, Shah FA, Ishtiaq N, Jamil N et al. COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes. PLoS ONE. 2021;16(8 August).","journal-title":"PLoS ONE"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis","volume":"11","author":"Ssentongo P","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1).","journal-title":"Sci Rep"},{"key":"ref5","author":"Richardson AN","year":"2010","unstructured":"Richardson AN, Pollak EA, Williams D, Smith MA. Intrauterine Infection. In: Comprehensive Toxicology, Second Edition. Elsevier Inc.; 2010. pp. 239\u201358."},{"key":"ref6","first-page":"E540","volume-title":"The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis","author":"Wei SQ","year":"2021","unstructured":"Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis. Volume 193. CMAJ. Canadian Medical Association; 2021. pp. E540\u20138."},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234187","article-title":"Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review","volume":"15","author":"Smith V","year":"2020","unstructured":"Smith V, Seo D, Warty R, Payne O, Salih M, Chin KL et al. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review. PLoS ONE. 2020;15(6).","journal-title":"PLoS ONE"},{"issue":"20","key":"ref8","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.2022.5906","article-title":"Association of SARS-CoV-2 Infection during Pregnancy with Maternal and Perinatal Outcomes","volume":"327","author":"McClymont E","year":"2022","unstructured":"McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, et al. Association of SARS-CoV-2 Infection during Pregnancy with Maternal and Perinatal Outcomes. JAMA. 2022;327(20):1983\u201391.","journal-title":"JAMA"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.7196\/SAMJ.2021.v111i12.15683","article-title":"Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV","volume":"111","author":"Waard L","year":"2021","unstructured":"de Waard L, Langenegger E, Erasmus K, van der Merwe T, Olivier SE, du Toit N, et al. Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. South Afr Med J. 2021;111(12):1174\u201380.","journal-title":"South Afr Med J"},{"issue":"20","key":"ref10","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.2022.5906","article-title":"Association of SARS-CoV-2 Infection during Pregnancy with Maternal and Perinatal Outcomes","volume":"327","author":"McClymont E","year":"2022","unstructured":"McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, et al. Association of SARS-CoV-2 Infection during Pregnancy with Maternal and Perinatal Outcomes. JAMA. 2022;327(20):1983\u201391.","journal-title":"JAMA"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S2589-7500(21)00250-8","article-title":"The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study","volume":"4","author":"Piekos SN","year":"2022","unstructured":"Piekos SN, Roper RT, Hwang YM, Sorensen T, Price ND, Hood L, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit Health. 2022;4(2):e95\u2013104.","journal-title":"Lancet Digit Health"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: A systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst P","year":"1998","unstructured":"Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: A systematic review of the literature and meta-analysis. BJOG. 1998;105(8):836\u201348.","journal-title":"BJOG"},{"key":"ref13","author":"Stringer EM","year":"2018","unstructured":"Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F et al. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy. PLoS One. 2018;13(7)."},{"issue":"1","key":"ref14","first-page":"31","article-title":"SYSTEMATIC REVIEW Antiretroviral Therapy and Pregnancy Outcomes in Developing Countries: A Systematic Review","volume":"3","author":"Mazengia Alemu F","year":"2015","unstructured":"Mazengia Alemu F, Worku Yalew A, Fantahun M, Ebasi Ashu E. SYSTEMATIC REVIEW Antiretroviral Therapy and Pregnancy Outcomes in Developing Countries: A Systematic Review. Int J MCH AIDS. 2015;3(1):31\u201343.","journal-title":"Int J MCH AIDS"},{"key":"ref15","volume-title":"Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy","author":"Lokken EM","year":"2021","unstructured":"Lokken EM, Mathur A, Bunge KE, Fairlie L, Makanani B, Beigi R, et al. Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy. Frontiers in Reproductive Health. Volume 3. Frontiers Media SA; 2021."},{"key":"ref16","author":"Turner AN","year":"2013","unstructured":"Turner AN, Tabbah S, Mwapasa V, Rogerson SJ, Meshnick SR, Ackerman WE, AND PREVENTION. Severity of Maternal HIV-1 Disease Is Associated With Adverse Birth Outcomes in Malawian Women: A Cohort Study [Internet]. EPIDEMIOLOGY. 2013. Available from: http:\/\/links.lww.com\/QAI\/A445"},{"key":"ref17","author":"Donald M","unstructured":"Donald M. Thea richard WSVPKBTBSOPBMEJAMBamji. The effect of maternal viral load on the risk of perinatal transmission of HIV-1."},{"key":"ref18","unstructured":"UNAIDS. 2022-global-aids-update_en. 2022."},{"key":"ref19","unstructured":"Ministry of Health (MOH) M. Malawi Population-based HIV Impact Assessment 2020\u20132021 Malawi Population-based HIV Impact Assessment MPHIA 2020\u20132021. Malawi Population-based HIV Impact Assessment 2020\u20132021 (MPHIA 2020\u20132021): [Internet]. 2021; Available from: http:\/\/phia.icap.columbia.edu"},{"issue":"13","key":"ref20","first-page":"S76","article-title":"SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020","volume":"28","author":"Theu JA","year":"2022","unstructured":"Theu JA, Kabaghe AN, Bello G, Chitsa-Banda E, Kagoli M, Auld A, et al. SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020. Emerg Infect Dis. 2022;28(13):S76\u201384.","journal-title":"Emerg Infect Dis"},{"key":"ref21","author":"Banda L","unstructured":"Banda L, Ho A, Kasenda S, Read JM, Jewell C, Price A et al. Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study. International Journal of Infectious Diseases [Internet]. 2023 Dec 1 [cited 2025 Feb 22];137:118. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10695832\/"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/AOG.0000000000005020","article-title":"Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status","volume":"141","author":"Jackson-Gibson M","year":"2023","unstructured":"Jackson-Gibson M, Diseko M, Caniglia EC, Mayondi GK, Mabuta J, Luckett R, et al. Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status. Obstet Gynecol. 2023;141(1):135\u201343.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/hiv.13037","article-title":"Immune deficiency is a risk factor for severe COVID-19 in people living with HIV","volume":"22","author":"Hoffmann C","year":"2021","unstructured":"Hoffmann C, Casado JL, H\u00e4rter G, Vizcarra P, Moreno A, Cattaneo D, et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021;22(5):372\u20138.","journal-title":"HIV Med"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26137-7","article-title":"Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV","volume":"12","author":"Alrubayyi A","year":"2021","unstructured":"Alrubayyi A, Gea-Mallorqu\u00ed E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12(1).","journal-title":"Nat Commun"},{"key":"ref25","author":"Gonz\u00e1lez R","year":"2022","unstructured":"Gonz\u00e1lez R, Nhampossa T, Figueroa-Romero A, Mendes A, Mazuze M, Garc\u00eda-Otero L et al. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women [Internet]. 2022. Available from: www.jaids.com"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-021-00355-x","article-title":"Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy","volume":"18","author":"Izzo I","year":"2021","unstructured":"Izzo I, Carriero C, Gardini G, Fumarola B, Chiari E, Castelli F et al. Impact of COVID-19 pandemic on HIV viremia: a single-center cohort study in northern Italy. AIDS Res Ther. 2021;18(1).","journal-title":"AIDS Res Ther"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and Neonatal Morbidity and Mortality among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study","volume":"175","author":"Villar J","year":"2021","unstructured":"Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality among Pregnant Women with and without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817\u201326.","journal-title":"JAMA Pediatr"},{"key":"ref28","first-page":"10","article-title":"Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in Malawi","volume":"13","author":"Nampota-Nkomba N","unstructured":"Nampota-Nkomba N, Buchwald A, Nyirenda OM, Mkandawire FA, Masonga R, Meja S, Moyo D, Cairo C, Laufer MK, REFINE Study Team. Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in Malawi. JAIDS J Acquir Immune Defic Syndr. 2022 May;13:10\u201397.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"ref29","author":"Premkumar L","year":"2020","unstructured":"Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann AJ et al. The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients [Internet]. Vol. 5, Sci. Immunol. 2020. Available from: https:\/\/www.science.org"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01138-21","article-title":"The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery","volume":"59","author":"Peghin M","year":"2021","unstructured":"Peghin M, De Martino M, Fabris M, Palese A, Visintini E, Graziano E et al. The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery. J Clin Microbiol. 2021;59(11).","journal-title":"J Clin Microbiol"},{"issue":"9","key":"ref31","article-title":"Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 Infection","volume":"12","author":"Lugo-Trampe A","year":"2024","unstructured":"Lugo-Trampe A, L\u00f3pez-Cifuentes D, Mendoza-P\u00e9rez P, Tafurt-Cardona Y, Joo-Dom\u00ednguez A, de Rios-Ibarra J. CP, Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 Infection. Healthc (Switzerland). 2024;12(9).","journal-title":"Healthc (Switzerland)"},{"key":"ref32","author":"Pathirana J","unstructured":"Pathirana J, Mu\u00f1oz FM, Abbing-Karahagopian V, Bhat N, Harris T, Kapoor A et al. Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine [Internet]. 2016 Dec 12 [cited 2024 Apr 7];34(49):6027. Available from: \/pmc\/articles\/PMC5139812\/"},{"key":"ref33","unstructured":"Stillbirth [Internet]. [cited 2024 Apr 7]. Available from: https:\/\/www.who.int\/health-topics\/stillbirth#tab=tab_1"},{"key":"ref34","author":"Cutland CL","unstructured":"Cutland CL, Lackritz EM, Mallett-Moore T, Bardaj\u00ed A, Chandrasekaran R, Lahariya C et al. Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine [Internet]. 2017 Dec 12 [cited 2024 Apr 7];35(48Part A):6492. Available from: \/pmc\/articles\/PMC5710991\/."},{"key":"ref35","author":"Schlaudecker EP","unstructured":"Schlaudecker EP, Munoz FM, Bardaj\u00ed A, Boghossian NS, Khalil A, Mousa H et al. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine [Internet]. 2017 Dec 12 [cited 2024 Apr 7];35(48Part A):6518. Available from: \/pmc\/articles\/PMC5710996\/."},{"key":"ref36","unstructured":"Preterm birth [Internet]. [cited 2024 Apr 7]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/preterm-birth"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009495","article-title":"Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: An individual participant data meta-analysis","volume":"8","author":"Smith ER","year":"2023","unstructured":"Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y et al. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: An individual participant data meta-analysis. BMJ Glob Health. 2023;8(1).","journal-title":"BMJ Glob Health"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab240","author":"Bruce-Brand C","year":"2021","unstructured":"Bruce-Brand C, Wright CA, Schubert PT, HIV. Placental Pathology, and Birth Outcomes\u2014a Brief Overview. J Infect Dis [Internet]. 2021 Dec 8 [cited 2025 Feb 1];224(Supplement_6):S683\u201390. Available from: https:\/\/dx.doi.org\/10.1093\/infdis\/jiab240"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.placenta.2021.09.006","article-title":"Placental pathology in women with HIV","volume":"115","author":"Ikumi NM","year":"2021","unstructured":"Ikumi NM, Matjila M, Gray CM, Anumba D, Pillay K. Placental pathology in women with HIV. Placenta. 2021;115:27\u201336.","journal-title":"Placenta"},{"key":"ref40","author":"Vyas P","year":"2021","unstructured":"Vyas P, Mathad JS, Leu CS, Naik S, Alexander M, Ara\u00fajo-Pereira M et al. Impact of HIV status on systemic inflammation during pregnancy. AIDS [Internet]. 2021 Nov 15 [cited 2025 Feb 1];35(14):2259. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8563396\/"},{"key":"ref41","author":"Wong YP","unstructured":"Wong YP, Tan GC, Omar SZ, Mustangin M, Singh Y, Salker MS et al. SARS-CoV-2 Infection in Pregnancy: Placental Histomorphological Patterns, Disease Severity and Perinatal Outcomes. Int J Environ Res Public Health [Internet]. 2022 Aug 1 [cited 2025 Feb 1];19(15):9517. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9368100\/"},{"key":"ref42","author":"Yao Y","unstructured":"Yao Y, Sun L, Luo J, Qi W, Zuo X, Yang Z. The effect of long-term COVID-19 infection on maternal and fetal complications: a retrospective cohort study conducted at a single center in China. Sci Rep [Internet]. 2024 Dec 1 [cited 2025 Feb 1];14(1):17273. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11283478\/"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6787028\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6787028\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:58:12Z","timestamp":1770199092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6787028\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":42,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6787028\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,7,8]]},"subtype":"preprint"}}